Rona Therapeutics
Rona Therapeutics｜Innovative siRNA Medicines & RNA Therapeutics Platform
- Employees
- 11–50
- Business Model
- B2B
- Website
- ronatherapeutics.com
- Total Funding
- $93.0M
- Last Round
- $25.0M Series BMar 2025
- Rounds
- 3
About
RNA medicine company developing next-generation siRNA-based therapies targeting metabolic diseases with a pipeline of investigational treatments.
Summary
Rona Therapeutics is a Biotech company. It has raised $93.0M in total across 3 rounds, most recently a $25.0M Series B round in Mar 2025. Investors include Lilly Asia Ventures, Geuniom Group and LongRiver Investments.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company